From advocacy to austerity: The new role of the U.S. public sector in HIV drug development and access

References

• Basu, S., Carney, M. A., & Kenworthy, N. J. (2017). Ten years after the financial crisis: The long reach of austerity and its global impacts on health. Social Science & Medicine, 187, pp. 203-207. doi: 10.1016/j.socscimed.2017.06.026
   PubMed Web of Science ®Google Scholar
• Bernstein, R. (1989). Bristol-Myers Squibb company: Strategic analysis/financial forecast.
   Google Scholar
• Biehl, J. (2004). The activist state: Global pharmaceuticals, AIDS, and citizenship in Brazil. Social Text, 22(3), pp. 105-132. doi: 10.1215/01642472-22-3_80-105
   Google Scholar
• Biehl, J. (2007). Will to live: AIDS therapies and the politics of survival. Princeton: Princeton University Press.
   Google Scholar
• Chadwick, V. (2019). Global fund claims last-minute victory on $14B replenishment target | Devex. Devex Retrieved from https://www.devex.com/news/global-fund-claims-last-minute-victory-on-14b-replenishment-target-95800/amp
   Google Scholar
• Cohen, J. (2018). A campaign to end AIDS by 2030 is faltering worldwide. Science | American Association for the Advancement of Science (AAAS) Retrieved from files/12116/campaign-end-aids-2030-faltering-worldwide.html
   Google Scholar
• Crane, J. T. (2013). Scrambling for Africa: AIDS, expertise, and the Rise of American global health Science. Ithaca, NY: Cornell University Press.
   Google Scholar
• Crunchbase. Acquisitions. Crunchbase Retrieved from https://www.crunchbase.com/search/acquisitions
   Google Scholar
• Davis, S. L. M., Goedel, W. C., Emerson, J., & Guven, B. S. (2017). Punitive laws, key population size estimates, and global AIDS response progress reports: An ecological study of 154 countries. Journal of the International AIDS Society, 20(1). doi: 10.7448/IAS.20.1.21386
   PubMedGoogle Scholar
• U.S. Food & Drug Administration (FDA). (2019). Drugs@FDA: FDA Approved Drug Products. Retrieved from https://www.accessdata.fda.gov/scripts/cder/daf/
   Google Scholar
• Emmons, W., & Nimgade, A. (1991). Burroughs Wellcome and AZT (A). Harvard Business Review Retrieved from https://hbr.org/product/Burroughs-Wellcome-and-AZ/an/792004-PDF-ENG
   Google Scholar
• Epstein, S. (1995). The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trials. Science, Technology, & Human Values, 20(4), pp. 408-437. doi: 10.1177/016224399502000402
   PubMed Web of Science ®Google Scholar
• Epstein, S. (1996). Impure science: AIDS, activism, and the politics of knowledge. Berkeley: University of California Press.
   Google Scholar
• Farmer, P. (2001). Infections and inequalities: The modern plagues. Oakland: University of California Press.
   Google Scholar
• Fisher, W. W., & Rigamonti, C. P. (2005). The South Africa AIDS controversy: A case study in patent law and policy. Harvard Law School (The Law and Business of Patents)
   Google Scholar
• Fleming, L., Greene, H., Li, G., Marx, M., & Yao, D. (2019). Government-funded research increasingly fuels innovation. Science, 364(6446), pp. 1139-1141. doi: 10.1126/science.aaw2373
   PubMed Web of Science ®Google Scholar
• Gere, C. (2017). Pain, pleasure, and the greater good. Chicago: The University of Chicago Press.
   Google Scholar
• Green, A. (2019). What's behind PEPFAR's funding cut threats? Devex Retrieved from https://www.devex.com/news/what-s-behind-pepfar-s-funding-cut-threats-95053
   Google Scholar
• Hayden, C. (2003). When nature goes public: The making and unmaking of bioprospecting in Mexico. Princeton: Princeton University Press.
   Google Scholar
• Jasanoff, S. (2004). States of knowledge: The co-production of science and the social order (1 New ed.) London: Routledge.
   Google Scholar
• Kenworthy, N., Thomann, M., & Parker, R. (2018). From a global crisis to the ‘end of AIDS’: New epidemics of signification. Global Public Health, 13(8), pp. 960-971. doi: 10.1080/17441692.2017.1365373
   PubMed Web of Science ®Google Scholar
• LaMarca, A., Clumeck, N., Plettenberg, A., Domingo, P., Fu, K., Craig, C.,  … Scott, T. (2006). Efficacy and safety of a once-daily fixed-dose combination of Abacavir/Lamivudine compared with Abacavir twice daily and Lamivudine once daily as separate entities in antiretroviral-experienced HIV-1-infected patients (CAL30001 study). Jaids Journal of Acquired Immune Deficiency Syndromes, 41(5), pp. 598-606. doi: 10.1097/01.qai.0000214821.33905.5c
   PubMed Web of Science ®Google Scholar
• Lange, J. M. A., & Ananworanich, J. (2014). The discovery and development of antiretroviral agents. Antiviral Therapy, 19(Suppl 3), pp. 5-14. doi: 10.3851/IMP2896
   PubMed Web of Science ®Google Scholar
• Maitland, D., Jackson, A., Osorio, J., Mandalia, S., Gazzard, B. G., & Moyle, G. J. (2008). Switching from twice-daily Abacavir and lamivudine to the once-daily fixed-dose combination tablet of Abacavir and lamivudine improves patient adherence and satisfaction with therapy. HIV Medicine, 9(8), pp. 667-672. doi: 10.1111/j.1468-1293.2008.00618.x
   PubMed Web of Science ®Google Scholar
• M. S. F. Access Campaign. (2012). Untangling the web of antiretroviral drug pricing. Retrieved from www.msfaccess.org
   Google Scholar
• Murray, J., Elashoff, M., Iacono-Connors, L., Cvetkovich, T., & Struble, K. (1999). The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs. Aids (london, England), 13(7), pp. 797-804. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10357378files/12221/pubmed.html doi: 10.1097/00002030-199905070-00008
   PubMed Web of Science ®Google Scholar
• Nguyen, V.-K. (2010). The Republic of therapy: Triage and sovereignty in West Africa’s time of AIDS. Durham: Duke University Press.
   Google Scholar
• U.S. National Institutes of Health. (2019). NIH Categorical Spending -NIH Research Portfolio Online Reporting Tools (RePORT). Retrieved from https://report.nih.gov/categorical_spending.aspx.
   Google Scholar
• Nunn, A. (2009). The politics and history of AIDS treatment in Brazil New York: Springer-Verlag.
   Google Scholar
• Office of the Spokesperson. (2017). Secretary Tillerson Launches PEPFAR Strategy for Accelerating HIV/AIDS Epidemic Control. U.S. Mission to International Organizations in Geneva.
   Google Scholar
• O'Reilly, B. (1990). The inside story of the aids drug For the first time Burroughs Wellcome tells how it made crucial decisions on AZT that brought howls from Congress and gay groups. Some of its wounds were self-inflicted. - November 5, 1990. Fortune Magazine.
   Google Scholar
• Petryna, A. (2009). When experiments travel: Clinical trials and the global search for human subjects (1st ed.) Princeton: Princeton University Press.
   Google Scholar
• Pfeiffer, J. (2013). The struggle for a public sector: Pepfar in Mozambique. Princeton: Princeton University Press.
   Google Scholar
• Pink Sheet, The. (1988). RETROVIR U.S. SALES SURPASS $100 MIL. IN FISCAL 1988, WELLCOME PLC DISCLOSES IN PRELIMINARY ANNUAL REPORT; ZOVIRAX IS TOP-SELLING DRUG WITH SALES OF $365 MIL.
   Google Scholar
• Rajan, K. S. (2006). Biocapital: The constitution of postgenomic life (1st ed.) Durham: Duke University Press Books.
   Google Scholar
• Rose, S., & Janeen Madan, K. (2019). With budget cuts looming again, Can PEPFAR Keep the gas on its acceleration strategy? Center For Global Development Retrieved from https://www.cgdev.org/blog/budget-cuts-looming-again-can-pepfar-keep-gas-its-acceleration-strategy
   Google Scholar
• ‘t Hoen, E., Berger, J., Calmy, A., & Moon, S. (2011). Driving a decade of change: HIV/AIDS, patents and access to medicines for all. Journal of the International AIDS Society, 14, 15. doi: 10.1186/1758-2652-14-15
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2017). Ending AIDS: Progress towards the 90–90–90 targets. https://www.unaids.org/en/resources/documents/2017/20170720_Global_AIDS_update_2017
   Google Scholar
• UNAIDS. (2019). Global HIV & AIDS statistics — 2019 fact sheet. Retrieved from https://www.unaids.org/en/resources/fact-sheet
   Google Scholar
• UNAIDS, W. H. O. (2002). Accelerating access initiative: Widening access to care and support for people living with HIV/AIDS Retrieved from https://www.who.int/hiv/pub/prev_care/aai/en/
   Google Scholar
• U.S. President’s Emergency Plan for AIDS Relief. (2016). PEPFAR Budget, 2004–2017. Retrieved from https://www.pepfar.gov/documents/organization/252516.pdf
   Google Scholar
• Whyte, S. R., Geest, S. v. d., & Hardon, A. (2002). Social lives of medicines. Cambridge: Cambridge University Press.
   Google Scholar